KovaDx is bridging the health disparity faced by people with sickle cell disease, as well as, other hemolytic anemias.
KovaDx has raised $256K in total funding. The most recent round was Grant. The last funding was announced in August 2021.
KovaDx's investors include National Science Foundation, Expert Dojo, CITRIS Foundry.
KovaDx is headquartered in New Haven, United States.
KovaDx is bridging the health disparity faced by people with sickle cell disease, as well as, other hemolytic anemias.
KovaDx is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"KovaDx — Funding & Investors." VCBacked, August 10, 2021, https://www.vcbacked.co/company/kovadx. Accessed October 17, 2026.
VCBacked. (2021). KovaDx — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/kovadx
{{cite web |title=KovaDx — Funding & Investors |url=https://www.vcbacked.co/company/kovadx |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated